Cargando…
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India
Gene and cell therapies for a variety of life-limiting illnesses are under investigation, and a small number of commercial products have successfully obtained regulatory approval. The cost of treatment is high, and clinical studies evaluating safety and efficacy are performed predominately in high-i...
Autores principales: | Cornetta, Kenneth, Bonamino, Martín, Mahlangu, Johnny, Mingozzi, Federico, Rangarajan, Savita, Rao, Jayandharan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171243/ https://www.ncbi.nlm.nih.gov/pubmed/35390542 http://dx.doi.org/10.1016/j.ymthe.2022.04.002 |
Ejemplares similares
-
The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial
por: Lentz, Steven R., et al.
Publicado: (2017) -
The roles and training of primary care doctors: China, India, Brazil and South Africa
por: Mash, Robert, et al.
Publicado: (2015) -
Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators
por: Rezaie, Rahim, et al.
Publicado: (2012) -
A bibliometric study on the research outcome of Brazil, Russia, India, China, and South Africa
por: I Narayan, Aparna, et al.
Publicado: (2021) -
A cohort study of the relationship between anaemia, mean corpuscular volume and mortality among a CKD population in South Africa
por: Nalado, Aishatu, et al.
Publicado: (2021)